A Phase II Trial of JDQ443 in <i>KRAS G12C</i>-Mutated NSCLC with PD-L1 Expression <1% or PD-L1 Expression ≥1% and an <i>STK11</i> Co-Mutation
| dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | |
| dc.contributor.author | LINDSAY, C. | |
| dc.contributor.author | VELUSWAMY, R. | |
| dc.contributor.author | CASTRO JUNIOR, G. | |
| dc.contributor.author | TAN, D. Y. H. | |
| dc.contributor.author | CAPARICA, R. | |
| dc.contributor.author | GLASER, S. | |
| dc.contributor.author | MALHOTRA, S. | |
| dc.contributor.author | FELIP, E. | |
| dc.contributor.author | CHAN, E. | |
| dc.date.accessioned | 2024-03-08T15:15:03Z | |
| dc.date.available | 2024-03-08T15:15:03Z | |
| dc.date.issued | 2024 | |
| dc.description.conferencedate | NOV 30-DEC 02, 2023 | |
| dc.description.conferencelocal | New Orleans, LA | |
| dc.description.conferencename | Multidisciplinary Thoracic Cancers Symposium | |
| dc.description.index | MEDLINE | |
| dc.description.index | PubMed | |
| dc.description.index | WoS | |
| dc.identifier.citation | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, v.118, n.1, p.E13-E14, 2024 | |
| dc.identifier.eissn | 1879-355X | |
| dc.identifier.issn | 0360-3016 | |
| dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/58525 | |
| dc.language.iso | eng | |
| dc.publisher | ELSEVIER SCIENCE INC | eng |
| dc.relation.ispartof | International Journal of Radiation Oncology Biology Physics | |
| dc.rights | restrictedAccess | eng |
| dc.rights.holder | Copyright ELSEVIER SCIENCE INC | eng |
| dc.subject.wos | Oncology | eng |
| dc.subject.wos | Radiology, Nuclear Medicine & Medical Imaging | eng |
| dc.title | A Phase II Trial of JDQ443 in <i>KRAS G12C</i>-Mutated NSCLC with PD-L1 Expression <1% or PD-L1 Expression ≥1% and an <i>STK11</i> Co-Mutation | eng |
| dc.type | conferenceObject | eng |
| dc.type.category | meeting abstract | eng |
| dc.type.version | publishedVersion | eng |
| dspace.entity.type | Publication | |
| hcfmusp.affiliation.country | Espanha | |
| hcfmusp.affiliation.country | Inglaterra | |
| hcfmusp.affiliation.country | Estados Unidos | |
| hcfmusp.affiliation.country | Singapura | |
| hcfmusp.affiliation.country | Suíça | |
| hcfmusp.affiliation.countryiso | gb | |
| hcfmusp.affiliation.countryiso | us | |
| hcfmusp.affiliation.countryiso | sg | |
| hcfmusp.affiliation.countryiso | ch | |
| hcfmusp.affiliation.countryiso | es | |
| hcfmusp.author.external | LINDSAY, C.:Univ Manchester, Div Canc Sci, Manchester, Lancs, England; Christie NHS Fdn Trust, Manchester, Lancs, England | |
| hcfmusp.author.external | VELUSWAMY, R.:Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA | |
| hcfmusp.author.external | TAN, D. Y. H.:Natl Canc Ctr Singapore, Singapore, Singapore | |
| hcfmusp.author.external | CAPARICA, R.:Novartis Pharma AG, Basel, Switzerland | |
| hcfmusp.author.external | GLASER, S.:Novartis Pharma AG, Basel, Switzerland | |
| hcfmusp.author.external | MALHOTRA, S.:Novartis Pharmaceut, E Hanover, NJ USA | |
| hcfmusp.author.external | FELIP, E.:Vall Hebron Inst Oncol, Barcelona, Spain | |
| hcfmusp.author.external | CHAN, E.:Novartis Pharmaceut, E Hanover, NJ USA | |
| hcfmusp.contributor.author-fmusphc | GILBERTO DE CASTRO JUNIOR | |
| hcfmusp.description.beginpage | E13 | |
| hcfmusp.description.endpage | E14 | |
| hcfmusp.description.issue | 1 | |
| hcfmusp.description.volume | 118 | |
| hcfmusp.origem | WOS | |
| hcfmusp.origem.wos | WOS:001129462100024 | |
| hcfmusp.publisher.city | NEW YORK | eng |
| hcfmusp.publisher.country | USA | eng |
| relation.isAuthorOfPublication | 0df25c0f-1337-424e-b0f7-41d0fccb51fc | |
| relation.isAuthorOfPublication.latestForDiscovery | 0df25c0f-1337-424e-b0f7-41d0fccb51fc |